MedPath

Comparison of topical triomcinolone acetonide1/0% alone with combination therapy of topical retinoic acid 05/0% and triamcinolone acetonide1/0% in the treatmentofsymptomatic Geograpic tongue

Phase 2
Completed
Conditions
symptomatic Geographic Tongue.
Registration Number
IRCT201211062464N6
Lead Sponsor
Research center, International Campus,Dental faculty, Tehran university of scince
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
28
Inclusion Criteria

all the above 18-year-old patients with symptomatic geographic tongue who were able to use ointment; Exclusion criteria: history of systemic or topical corticosteroid use at least within a month before treatment? smokers? pregnant women ?those with any serious systemic disease that may interfere with the drug, such as diabetes; hypertension? heart disease ? neurological problems ? hepatitis ?renal disease ? chemotherapy and radiotherapy .

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.